Neuroprotective efficiency of tetanus toxin C fragment in model of global cerebral ischemia in Mongolian gerbils

Brain Research Bulletin

Volumn 101, Issue , 2014, Pages 37-44

  Radenovic, Lidija ^a   Selakovic, Vesna ^b   Olivan, Sara ^c   Calvo, Ana Cristina ^c   Rando, Amaya ^c   Janac, Branka ^a   Osta, Rosario ^c  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b MMA   (Serbia)

^c UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Global ischemia; Motor behavior; Neuroprotection; Oxidative stress; TTC

Indexed keywords

NEUROPROTECTIVE AGENT; NITRIC OXIDE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETANUS TOXIN; TETANUS TOXIN C; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; FOREBRAIN; GENE THERAPY; HIPPOCAMPUS; HYPERACTIVITY; LIPID PEROXIDATION; LOCOMOTION; MALE; MERIONES UNGUICULATUS; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STEREOTYPY;

GLOBAL ISCHEMIA; MOTOR BEHAVIOR; NEUROPROTECTION; OXIDATIVE STRESS; TTC;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CAROTID ARTERY, COMMON; DNA, RECOMBINANT; GENETIC THERAPY; GERBILLINAE; HYPERKINESIS; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PLASMIDS; RANDOM ALLOCATION; TETANUS TOXIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 84892653036     PISSN: 03619230     EISSN: 18732747     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2013.11.006     Document Type: Article

References (37)

1. Bazan N.G., Marcheselli V.L., Cole-Edwards K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 2005, 1053:137-147.
2. Block F. Global ischemia and behavioural deficits. Prog. Neurobiol. 1999, 58:279-295.
3. Bordet T., Castelnau-Ptakhine L., Fauchereau F., Friocourt G., Kahn A., Haase G. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin C fragment. Mol. Cell. Neurosci. 2001, 17:842-854.
4. Chaib-Oukadour I., Gil C., Aguilera J. The C-terminal domain of the heavy chain of tetanus toxin rescues cerebellar granule neurones from apoptotic death: involvement of phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways. J. Neurochem. 2004, 90:1227-1236.
5. Ciriza J., Garcia-Ojeda M., Martín-Burriel I., Agulhon C., Miana-Mena F.J., Munoz M.J., Zaragoza P., Brulet P., Osta R. Antiapoptotic activity maintenance of brain derived neurotrophic factor and the C fragment of the tetanus toxin genetic fusion protein. Cent. Eur. J. Biol. 2008, 3:105-112.
6. Ciriza J., Moreno-Igoa M., Calvo A.C., Yague G., Palacio J., Miana-Mena F.J., Muñoz M.J., Zaragoza P., BrÛlet P., Osta R. A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model. Restor. Neurol. Neurosci. 2008, 26:459-465.
7. Coen L., Osta R., Maury M., BrÛlet P. Construction of hybrid proteins that migrate retrogradely and transynaptically into the central nervous system. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:9400-9405.
8. Evinger C., Erichsen J.T. Transsynaptic retrograde transport of fragment C of tetanus toxin demonstrated by immunohistochemical localization. Brain Res. 1986, 380:383-388.
9. Gil C., Chaib-Oukadour I., Aguilera J. C-terminal fragment of tetanus toxin heavy chain activates Akt and MEK/ERK signalling pathways in a Trk receptor-dependent manner in cultured cortical neurons. Biochem. J. 2003, 373:613-620.
10. Groenewegen H.J. The basal ganglia and motor control. Neural Plast. 2003, 10:107-120.
11. Guevara I., Iwanejko J., Dembińska-Kieć A., Pankiewicz J., Wanat A., Anna P., Golabek I., Bartuś S., Malczewska-Malec M., Szczudlik A. Determination of nitrite/nitrate in human biological material by the simple Griess reaction. Clin. Chim. Acta 1998, 274:177-188.
12. Hazell A.S. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem. Int. 2007, 50:941-953.
13. Hyun H., Lee J., Hwang D.W., Kim S., Hyun D.K., Choi J.S., Lee J.K., Lee M. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials 2011, 32:306-315.
14. Janac B., Selakovic V., Radenovic L. Temporal patterns of motor behavioural improvements by MK-801 in Mongolian gerbils submitted to different duration of global cerebral ischemia. Behav. Brain Res. 2008, 194:72-78.
15. Kluska M.M., Witte O.W., Bolz J., Redecker C. Neurogenesis in the adult dentate gyrus after cortical infarcts: effects of infarct location, N-methyl-d-aspartate receptor blockade and anti-inflammatory treatment. Neuroscience 2005, 135:723-735.
16. Kuroiwa T., Bonnekoh P., Hossmann K.A. Prevention of postischemic hyperthermia prevents ischemic injury of CA1 neurons in gerbils. J. Cereb. Blood Flow Metab. 1990, 10:550-556.
17. Larsen K.E., Benn S.C., Ay I., Chian R.J., Celia S.A., Remington M.P., Bejarano M., Liu M., Ross J., Carmillo P., Sah D., Phillips K.A., Sulzer D., Pepinsky R.B., Fishman P.S., Brown R.H., Francis J.W. A glial cell line-derived neurotrophic factor (GDNF): tetanus toxin fragment C protein conjugate improves delivery of GDNF to spinal cord motor neurons in mice. Brain Res. 2006, 1120:1-12.
18. Li S.F., Sun Y.B., Meng Q.H., Li S.R., Yao W.C., Hu G.J., Li Z.J., Wang R.Z. Recombinant adeno-associated virus serotype 1-vascular endothelial growth factor promotes neurogenesis and neuromigration in the subventricular zone and rescues neuronal function in ischemic rats. Neurosurgery 2009, 65:771-779.
19. Longstreth W.T., Meschke J.S., Davidson S.K., Smoot L.M., Smoot J.C., Koepsell T.D. Hypothesis: motor neuron toxin produced by a clostridial species residing in gut causes ALS. Med. Hypotheses 2005, 64:1153-1156.
20. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
21. Mehta S.L., Manhas N., Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54:34-66.
22. Mendieta L., Venegas B., Moreno N., Patricio A., Martínez I., Aguilera J., Limón I.D. The carboxyl-terminal domain of the heavy chain of tetanus toxin prevents dopaminergic degeneration and improves motor behavior in rats with striatal MPP(+)-lesions. Neurosci. Res. 2009, 65:98-106.
23. Miana-Mena F.J., Muñoz M.J., Yagüe G., Mendez M., Moreno M., Ciriza J., Zaragoza P., Osta R. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2005, 6:55-62.
24. Misra H.P., Fridovich I. The role of superoxide anion in the autooxidation of epinephrine and simple assay for superoxide dismutase. J. Biol. Chem. 1972, 247:3170-3175.
25. Moreno-Igoa M., Calvo A.C., Penas C., Manzano R., Oliván S., Muñoz M.J., Mancuso R., Zaragoza P., Aguilera J., Navarro X., Osta R. Fragment C of tetanus toxin, more than a carrier. Novel perspectives in non-viral ALS gene therapy. J. Mol. Med. 2010, 88:297-308.
26. Nagel S., Papadakis M., Hoyte L., Buchan A.M. Therapeutic hypothermia in experimental models of focal and global cerebral ischemia and intracerebral hemorrhage. Expert Rev. Neurother. 2008, 8:1255-1268.
27. Ohtaki H., Takeda T., Dohi K., Yofu S., Nakamachi T., Satoh K., Hiraizumi Y., Miyaoka H., Matsunaga M., Shioda S. Increased mitochondrial DNA oxidative damage after transient middle cerebral artery occlusion in mice. Neurosci. Res. 2007, 58:349-355.
28. Pendharkar A.V., Chua J.Y., Andres R.H., Wang N., Gaeta X., Wang H., De A., Choi R., Chen S., Rutt B.K., Gambhir S.S., Guzman R. Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia. Stroke 2010, 41:2064-2070.
29. 2+- and ascorbic acid-stimulated lipid peroxidation in vitro. J. Neurochem. 1980, 34:1630-1638.
30. Reiter R.J., Tan D.X., Manchester L.C., Tamura H. Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J. Physiol. Pharmacol. 2007, 58:5-22.
31. Selakovic V., Janac B., Radenovic L. MK-801 effect on regional cerebral oxidative stress rate induced by different duration of global ischemia in gerbils. Mol. Cell. Biochem. 2010, 342:35-50.
32. Shi Q., Zhang P., Zhang J., Chen X., Lu H., Tian Y., Parker T.L., Liu Y. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice. Neurosci. Lett. 2009, 465:220-225.
33. Shigematsu H., Yasuda K., Iwai T., Sasajima T., Ishimaru S., Ohashi Y., Yamaguchi T., Ogihara T., Morishita R. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010, 17:1152-1161.
34. Sinha K., Box M., Lalli G., Schiavo G., Schneider H., Groves M., Siligardi G., Fairweather N. Analysis of mutants of tetanus Toxin Hc fragment: ganglioside binding, cell binding and retrograde axonal transport properties. Mol. Microbiol. 2000, 37:1041-1051.
35. Sjakste N., Gutcaits A., Kalvinsh I. Mildronate: an antiischemic drug for neurological indications. CNS Drug Rev. 2005, 11:151-168.
36. Spitz D.R., Oberley L.W. An assay for superoxide dismutase activity in mammalian tissue homogenates. Anal. Biochem. 1989, 179:8-18.
37. Takakusaki K., Saitoh K., Harada H., Kashiwayanagi M. Role of basal ganglia-brainstem pathways in the control of motor behaviors. Neurosci. Res. 2004, 50:137-151.